Skip to main content
Year archive

Dallah Healthcare Co. — 2026 filings

All 8 regulatory filings released by Dallah Healthcare Co. (4004) in 2026, sourced directly from the official regulator.

8 Filings
2026 Period
2026 filings (8)
Filing Released Lang
Dallah Healthcare Company invites its shareholders to attend the Ordinary General Assembly Meeting (First Meeting) via modern technology means.
Proxy Solicitation & Information Statement
2026-06-02 English
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the first quarter of 2026.
Notice of Dividend Amount
2026-05-10 English
Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )
Interim / Quarterly Report Q1 2026
2026-05-10 English
Dallah Healthcare Company announces the sale of its shares in Dr. Mohammed Bin Rashed Al Fagih & Partners Company for a value of SAR 497,983,407
Capital/Financing Update
2026-05-06 English
Dallah Healthcare Company announces recent developments in relation to the acquisition of shares in Al-Ahsa Medical Services Company (Dallah Al-Ahsa Hospital)
M&A Activity
2026-04-23 English
Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares
Share Issue/Capital Change
2026-03-04 English
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025.
Notice of Dividend Amount
2026-03-04 English
Dallah Healthcare Co. announces its Annual Financial results for the period ending on 2025-12-31
Earnings Release FY 2025
2026-03-04 English